The closest thing to a top pick in medical marijuana for migraines is a CBD-dominant product with trace THC that comes with a third-party certificate of analysis (COA). That is not because CBD is proven to prevent or stop migraine attacks. It is because CBD-dominant products carry the mildest side effect profile, the least impairment risk, and the widest legal access in the United States, which makes them the most reasonable starting point for someone who wants to experiment under medical supervision. I ranked the four main cannabinoid categories by five criteria: strength of published evidence, THC-to-CBD ratio, side effect and impairment load, lab-testing transparency, and legal availability by state.
What the clinical evidence actually shows
Be clear about the state of the science before spending money. The American Headache Society issued a position statement in 2021 stating that there is insufficient evidence to recommend cannabis or cannabinoids for primary headache disorders, including migraine, and that use should be limited to clinical trials. Cochrane reviews of cannabinoids for chronic pain have rated the evidence as low to very low certainty, and those reviews cover chronic pain broadly, not migraine specifically. Observational studies, including a 2019 survey published in the Journal of Headache and Pain, have reported that some patients with chronic migraine who used cannabis products saw fewer headache days per month, but observational data cannot separate the drug from placebo, expectancy, and concurrent preventive treatment.
medical cannabis for migraine relief
Translation: cannabinoids are an experimental option, not a first-line migraine treatment. Triptans, gepants, beta blockers, topiramate, CGRP monoclonal antibodies, and other FDA-approved therapies have far better evidence behind them.
Category 1: CBD-dominant products (high CBD, trace THC)
These products come as oils, capsules, or tinctures, and under federal law they must contain no more than 0.3 percent THC on a dry weight basis. In states with medical cannabis programs you can find CBD-dominant products with slightly more THC than that limit.
- Pros: minimal psychoactivity, no meaningful impairment for most users, legal in most states without a cannabis card, widely available, easy to stop without withdrawal concerns.
- Cons: no migraine-specific evidence, quality varies enormously between brands, CBD can interact with blood thinners, anti-seizure drugs, and some antidepressants through liver enzymes, and the effective dose is unknown.
Best for: a first, cautious trial in someone who wants to avoid THC and who is already cleared by a neurologist, especially a patient taking few other medications.
Category 2: Full-spectrum and broad-spectrum CBD
Full-spectrum extracts keep the plant's minor cannabinoids and terpenes, along with trace THC. Broad-spectrum products remove most or all THC while keeping other compounds. The theory that these compounds work better together is often called the entourage effect, and it remains largely unproven in human migraine research.
- Pros: possibly better tolerated than isolate for some users, trace THC may add mild benefit, still low impairment risk at typical serving sizes.
- Cons: trace THC can accumulate and may show up on an employment drug screen, the entourage effect is a hypothesis rather than a demonstrated migraine mechanism, and labels frequently misstate cannabinoid content unless a COA is provided.
Best for: people who tried CBD isolate without any change and want a broader extract, provided their job does not involve drug testing.
Category 3: Balanced THC-to-CBD products
These typically sit near a 1:1 ratio and require a medical cannabis card in most states. This is the category most often discussed in patient surveys about migraine relief.
- Pros: THC has the strongest biological rationale for acute pain and nausea, CBD may blunt some THC anxiety and sedation, useful during an attack when nausea limits oral medication.
- Cons: impairment makes driving and work unsafe, risk of dependency and cannabis use disorder, cognitive effects, potential for rebound or medication-overuse patterns, limited and low-quality migraine-specific trials, and no standardized dosing.
Best for: patients in legal medical programs with frequent attacks who have failed multiple FDA-approved preventives, and who can avoid driving or operating machinery after use.
Category 4: High-THC medical cannabis
- Pros: fastest onset when inhaled, most likely to produce perceptible acute effects, available in states with established programs.
- Cons: highest impairment and dependency risk, smoked and vaped routes carry respiratory harms, highest likelihood of anxiety, paranoia, and cyclical vomiting in susceptible users, weakest migraine-specific evidence of any category.
Best for: rare, carefully supervised cases under a physician who is tracking headache frequency, and generally not a sensible first choice.
How to screen any product before you buy
- Ask for a batch-specific COA from an ISO-accredited third-party lab, not a generic report.
- Check that measured cannabinoid content matches the label within a reasonable margin.
- Confirm the panel includes pesticides, heavy metals, residual solvents, and microbials.
- Note the harvest or manufacture date; cannabinoid content drifts with age and light exposure.
- Record your headache days before and during use so you can judge whether anything changed.
When medical marijuana is the wrong tool
Skip cannabinoids if you are pregnant or breastfeeding, have a personal or family history of psychosis, have uncontrolled cardiac disease, or are taking medications that interact with CBD. Also skip them as a replacement for an effective migraine preventive. A headache specialist or neurologist should review your full medication list, because CBD inhibits CYP enzymes and can raise blood levels of several drugs.
Bottom line
A CBD-dominant, lab-verified product is the most defensible starting point if you want to try cannabinoids for migraine, with full-spectrum as a second option for people without drug-testing concerns and balanced or high-THC products reserved for supervised medical cannabis patients who have exhausted standard care. Track your headache days, keep your neurologist informed, and treat any improvement as a personal observation rather than proof of efficacy.